Cargando…
Perhexiline Therapy in Patients with Type 2 Diabetes: Incremental Insulin Resistance despite Potentiation of Nitric Oxide Signaling
Perhexiline (Px) inhibits carnitine palmitoyltransferase 1 (CPT1), which controls uptake of long chain fatty acids into mitochondria. However, occasional cases of hypoglycaemia have been reported in Px-treated patients, raising the possibility that Px may also increase sensitivity to insulin. Furthe...
Autores principales: | Chong, Cher-Rin, Liu, Saifei, Imam, Hasan, Heresztyn, Tamila, Sallustio, Benedetta C., Chirkov, Yuliy Y., Horowitz, John D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598312/ https://www.ncbi.nlm.nih.gov/pubmed/36289640 http://dx.doi.org/10.3390/biomedicines10102381 |
Ejemplares similares
-
Prolonged suppression of the anti‐oxidant/anti‐inflammatory effects of BNP post‐Takotsubo syndrome
por: Liu, Saifei, et al.
Publicado: (2020) -
Does cardiac resynchronization therapy restore peripheral circulatory homeostasis?
por: Ajaero, Chukwudiebube N., et al.
Publicado: (2017) -
Nitric oxide resistance at the platelet level: pathophysiology and therapeutic implications
por: Horowitz, John, et al.
Publicado: (2009) -
Neutrophil-Initiated Myocardial Inflammation and Its Modulation by B-Type Natriuretic Peptide: A Potential Therapeutic Target
por: Liu, Saifei, et al.
Publicado: (2018) -
Impairment of Anti-Aggregatory Responses to Nitric Oxide and Prostacyclin: Mechanisms and Clinical Implications in Cardiovascular Disease
por: Chirkov, Yuliy Y., et al.
Publicado: (2022)